ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 616348 Irinotecan hydrochloride 0.00104257542638397 0.61035207
NSC 681636 Camptothecin Derivative 0.00104257542638397 0.5951131
NSC 681645 Camptothecin Derivative 0.00104257542638397 0.62933413
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00104257542638397 0.52233469
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.00104257542638397 0.56591111
NSC 628665 Null 0.00131875202369342 0.60277314
NSC 629867 Null 0.00131875202369342 0.32322952
NSC 642329 Naphtho[2,3-c]furan-1(9a)-one, 3,3a,4,9-tetrahydro-4- (4-fluorophenyl)-6,7-dimethoxy-9-(4-hydroxy-3,5- dimethoxyphenyl)- 0.00131875202369342 0.48505831
NSC 639174 Camptothecin Derivative 0.00134664791567076 0.59182531
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00134664791567076 0.57450613
Total:64  Current:4    [First] [Prev] [Next] [Last]